Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.

Authors :: Calfa, Carmen Julia
Rothe, Michael
Srkalovic, Gordan
Duvivier, Herbert Leon
Behl, Deepti
Straughn, J Michael
Yost, Kathleen J
Mehmi, Inderjit
Pisick, Evan P.
Sharma, Bhavina B
Thota, Ramya
Veljovich, Dan Steven
Alese, Olatunji B.
Cannon, Timothy Lewis
Gaba, Anu G.
Urba, Walter John
von Mehren, Margaret
Grantham, Gina N.
Halabi, Susan
Schilsky, Richard L.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3117-3117, 1p
Publication Year :: 2023

Full Text Access

Tools